Patents
featured
AUDUBON, Pa.-- Spinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson& Johnson Inc.. Globus said that the jury in the U.S. District Court in Delaware made its decision Monday.
» Read More
More
-
*Federal Circuit: Nintendo did not violate Motiva's rights. May 13- Nintendo Co, one of the world's largest makers of video game players, won a U.S. appeals court decision in a patent case that will allow it to keep importing its popular Wii system into the United States.
-
*Federal Circuit: Nintendo did not violate Motiva's rights. May 13- Nintendo Co, one of the world's largest makers of video game players, won a U.S. appeals court decision in a patent case that will allow it to keep importing its popular Wii system into the United States.
-
WASHINGTON, May 13- The U.S. Supreme Court ruled on Monday that an Indiana farmer violated agribusiness company Monsanto Co's patent for a type of soybean.
-
SAN FRANCISCO, May 3- Patent demands are taking a big toll on technology companies, with results that range from forcing companies to tweak their products to exiting their business altogether, according to a study from the Santa Clara University School of Law.
-
April 30- A federal judge has set new trial dates in November to decide whether $450.5 million of damages awarded by a jury to Apple Inc in a patent dispute with Samsung Electronics should stand, according to a court filing.
-
SEATTLE, April 26- Microsoft Corp came out on top in the first of two patent trials versus Google Inc's Motorola Mobility unit on Thursday, as a federal judge in Seattle ruled largely in its favor. District Judge James Robart in Seattle said Microsoft owed only a fraction of the royalties Motorola had claimed for use of its technology in Microsoft's Xbox console.
-
ZURICH, April 24- Novartis named Harry Kirsch as its new CFO, betting that his experience of improving performance at the Swiss drugmaker's pharmaceuticals division will help it navigate a wave of patent expiries.
-
WASHINGTON, April 22- Apple Inc scored a win on Monday when the U.S. International Trade Commission ruled that it did not violate a Google patent to make the popular iPhones. The smartphone industry has seen dozens of lawsuits on several continents as Apple and companies that make smartphones that use Google's Android software vie for market share.
-
CAPE TOWN, April 22- South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday.
-
The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.
-
*Oral arguments begin Monday in Myriad Genetics patent suit. NEW YORK, April 14- Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder.
-
GENEVA, April 8- India's Trade Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis.
-
WASHINGTON, April 5- Samsung Electronics Co Ltd infringed a key portion of an Apple Inc patent by including a text-selection feature in its smartphones and tablets, an International Trade Commission judge said in a preliminary decision.
-
LONDON/ MUMBAI, April 2- Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016..
-
MUMBAI/ NEW DELHI, April 1- India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics.
-
NEW DELHI, April 1- The Indian government hailed as "historic" a Supreme Court ruling on Monday against a plea by Swiss drugmaker Novartis AG to protect the patent on its drug Glivec.
-
MUMBAI, April 1- Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
-
NEW DELHI/ MUMBAI, April 1- India's top court rejected Swiss drugmaker Novartis AG's plea for patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals.
-
India's top court has dealt a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.
-
NEW DELHI/ MUMBAI, April 1- India's top court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.
Most Popular Video
DuckDuckGo CEO Gabriel Weinberg says web traffic on his search engine, billed as an alternative to Google that doesn't store your private information, surged 33 percent after the NSA news broke. Weinberg discusses the model of his search engine, and how the company makes money.
Wednesday, 19 Jun 2013 | 6:31 AM ETJohn Silvia, Wells Fargo Securities, and Barbara Marcin, Gabelli Dividend Income Fund, discuss whether investors should reconsider allocating their portfolios as the Fed wraps up its two-day policy meeting.
Wednesday, 19 Jun 2013 | 8:53 AM ETKen Langone, Invemed Associates chairman and president, called Fed Chairman Ben Bernanke a "lame duck."